Request Sample
Request discount

Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Analysis 2016-2020 and Forecast 2021-2027

Request Sample
Request Discount
Enquiry before buying
Need Customization

Report Description


The Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Report provides Insightful information to the clients enhancing their basic leadership capacity identified with the global Chemotherapy-Induced Nausea and Vomiting Drugs Market business, including market dynamics, segmentation, competition, and regional growth. The strategy of expansion has been adopted by key players who are increasing their production capacities to cater to the increasing demand for various application.

New traders at intervals the Chemotherapy-Induced Nausea and Vomiting Drugs Market face strong competition from ancient world traders as they try with technological revolutions, dependableness and commonplace of Chemotherapy-Induced Nausea and Vomiting Drugs Market product affairs. The report is at risk of project regarding this Chemotherapy-Induced Nausea and Vomiting Drugs Market evolutions and additionally the magnitude of competition, value and extra.

Leading market players: (Option 1: Free 25% Customization Profiles of 5 Additional Companies of your Choice)


This business intelligence report offers profiling of reputed companies that are operating in the market. Companies such as:

  • Merck & Co., Inc.
  • GlaxoSmithKline plc
  • Tesaro, Inc.
  • Helsinn Group
  • F. Hoffmann-La Roche Ltd.
  • Heron Therapeutics, Inc.
  • Dr. Reddy's Laboratories Ltd.
  • Acacia Pharma
  • Sun Pharmaceutical Industry Ltd.
  • Otsuka Holdings Co., Ltd.

Others players have been profiled into detail so as to offer a glimpse of the market leaders. Moreover, parameters such as Chemotherapy-Induced Nausea and Vomiting Drugs related investment & spending and developments by major players of the market are tracked in this Global report.

Years considered for the study:


Chemotherapy-Induced Nausea and Vomiting Drugs Market

Chemotherapy-Induced Nausea and Vomiting Drugs Market

Report Highlights:


The Chemotherapy-Induced Nausea and Vomiting Drugs Market is widely partitioned reliant on the predictable updates in the enhancement of parameters for example, quality, trustworthiness, end customer solicitations, applications, and others. The Chemotherapy-Induced Nausea and Vomiting Drugs Market report contains general successful parameters, confinements, and besides has in detail illumination of the noteworthy data close by the present and future examples that may concern the advancement. The comprehensive Chemotherapy-Induced Nausea and Vomiting Drugs Market report elucidates within and outside representation of current advancements, parameters, and establishments.

The key regions analyzed in this study include North America, Europe, Japan, China, India, Korea, South East Asia, South America, Middle East and African countries. The leading players of Chemotherapy-Induced Nausea and Vomiting Drugs Market and their geographical presence across the globe are estimated based on production capacity, utilization ratio, consumer base, demand and supply scenario, profit margin and Chemotherapy-Induced Nausea and Vomiting Drugs marketers.

Data Lab Forecast performed primary as well as exhaustive secondary research for this study. We conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, DLF was able to include manufacturers that could not be identified due to the limitations of secondary research. We analysed product offerings, distribution channel and regional presence of all major companies in the industry.

Data Lab Forecast calculated the market size for the Chemotherapy-Induced Nausea and Vomiting Drugs market using a bottom-up approach, wherein manufacturers value data for different type (Existing Drugs, Akynzeo (Netupitant-Palonosetron FDC), Aloxi (Palonosetron), Emend (Aprepitant), Kytril Generic (Granisetron), Zofran Generic (Ondansetron), Pipeline Drugs, SUSTOL (Granisetron Injection extended release), Rolapitant), of Chemotherapy-Induced Nausea and Vomiting Drugs market was recorded as well as forecast for the future years was made. Data Lab Forecast sourced these values from industry experts and company representatives, and externally validated through analyzing historical sales data of respective manufacturers to arrive at the overall market size. Various secondary sources such as company annual reports, white papers, investor presentations and financial reports were also studied by Data Lab Forecast.

Chemotherapy-Induced Nausea and Vomiting Drugs Market

Chemotherapy-Induced Nausea and Vomiting Drugs Market

Key Target Audience:


  • Chemotherapy-Induced Nausea and Vomiting Drugs market companies.
  • Research organizations and consulting companies.
  • Organizations, associations and alliances related to the Chemotherapy-Induced Nausea and Vomiting Drugs market industry.
  • Government bodies such as regulating authorities and policymakers.
  • Industry associations.

The study is useful in providing answers to several critical questions that are important for industry stakeholders, such as manufacturers, distributors, dealers and policymakers, about which market segments should be targeted over retail cosmetics outlets in coming years to strategize investments and capitalize on growth of the market.

Report Scope:


In this report, Chemotherapy-Induced Nausea and Vomiting Drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

In terms of type, the Global Chemotherapy-Induced Nausea and Vomiting Drugs market is segregated into:


The report includes in-detail references of all the notable product categories as well as application specifications. The product segment is described on the basis of key player development traits, sales overview, volume based returns and the like.

  • Existing Drugs
  • Akynzeo (Netupitant-Palonosetron FDC)
  • Aloxi (Palonosetron)
  • Emend (Aprepitant)
  • Kytril Generic (Granisetron)
  • Zofran Generic (Ondansetron)
  • Pipeline Drugs
  • SUSTOL (Granisetron Injection extended release)
  • Rolapitant

By end-user also classify into, the Global Chemotherapy-Induced Nausea and Vomiting Drugs market:


Global Chemotherapy-Induced Nausea and Vomiting Drugs market also specifically underpins end-use application scope and their improvements based on technological developments and consumer preferences.

  • Serotonin Receptor Antagonists
  • NK1 Receptor Antagonists

Highlights of this 2021-2027 Chemotherapy-Induced Nausea and Vomiting Drugs Market Report:

  • Market dynamics, Chemotherapy-Induced Nausea and Vomiting Drugs economy manufacturing, opportunities on the total pricing of this top manufacturer and improvement trend analysis;
  • Chemotherapy-Induced Nausea and Vomiting Drugs industry players at the general regional industry and economy synopsis;
  • Deep analysis of the most significant market players included by Worldwide Chemotherapy-Induced Nausea and Vomiting Drugs Market study report;
  • Understand more about the market plans that are increasingly now being adopted by leading Chemotherapy-Induced Nausea and Vomiting Drugs businesses;
  • Evaluation of this market character, namely market development drivers, essential challengers, inhibitors, and chances;
  • Strategically profile the key players and comprehensively analyze their growth strategies.

Competitive Landscape:

Company Profiles: Detailed analysis of the major companies presents in the Chemotherapy-Induced Nausea and Vomiting Drugs market.

Product Benchmarking: Benchmarking of most selling variant of all leading companies based on product type. In-depth analysis of benchmarking and recommendation on ideal product specifications.

Voice of Customer: Customer analysis by considering the major factors influencing the purchasing decision.

Available Customizations:

With the given market data, Data Lab Forecast offers customizations according to the companys specific needs. The following customization options are available for the report:

Channel Partner Analysis: Detailed list of distributors and dealers across the country.

Company Information: Detailed analysis and profiling of additional market players (up to five).

Product Information: Detailed analysis of new products in the market and their driving forces in the market.

In case you dont find what you are looking for, please get in touch with our custom research team at sales@datalabforecast.com

Table of Contents1 Industry Overview1.1 Chemotherapy-Induced Nausea and Vomiting Drugs IndustryFigure Chemotherapy-Induced Nausea and Vomiting Drugs Industry Chain Structure1.1.1 Overview1.1.2 Development of Chemotherapy-Induced Nausea and Vomiting Drugs1.2 Market Segment1.2.1 UpstreamTable Upstream Segment of Chemotherapy-Induced Nausea and Vomiting Drugs1.2.2 DownstreamTable Application Segment of Chemotherapy-Induced Nausea and Vomiting DrugsTable Global Chemotherapy-Induced Nausea and Vomiting Drugs Market 2016-2027, by Application, in USD Million1.2.3 COVID-19 Impact1.3 Cost Analysis2 Industry Environment (PEST Analysis)2.1 Policy2.2 Economics2.3 Sociology2.4 Technology3 Chemotherapy-Induced Nausea and Vomiting Drugs Market by Type3.1 By Type3.1.1 Existing DrugsTable Major Company List of Existing Drugs3.1.2 Akynzeo (Netupitant-Palonosetron FDC)Table Major Company List of Akynzeo (Netupitant-Palonosetron FDC)3.1.3 Aloxi (Palonosetron)Table Major Company List of Aloxi (Palonosetron)3.1.4 Emend (Aprepitant)Table Major Company List of Emend (Aprepitant)3.1.5 Kytril Generic (Granisetron)Table Major Company List of Kytril Generic (Granisetron)3.1.6 Zofran Generic (Ondansetron)Table Major Company List of Zofran Generic (Ondansetron)3.1.7 Pipeline DrugsTable Major Company List of Pipeline Drugs3.1.8 SUSTOL (Granisetron Injection extended release)Table Major Company List of SUSTOL (Granisetron Injection extended release)3.1.9 RolapitantTable Major Company List of Rolapitant3.2 Market SizeTable Global Chemotherapy-Induced Nausea and Vomiting Drugs Market 2016-2020, by Type, in USD MillionFigure Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Growth 2016-2020, by Type, in USD MillionTable Global Chemotherapy-Induced Nausea and Vomiting Drugs Market 2016-2020, by Type, in VolumeFigure Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Growth 2016-2020, by Type, in Volume3.3 Market ForecastTable Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Forecast 2021-2027, by Type, in USD MillionTable Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Forecast 2021-2027, by Type, in Volume4 Major Companies List4.1 Merck & Co., Inc. (Company Profile, Sales Data etc.)4.1.1 Merck & Co., Inc. ProfileTable Merck & Co., Inc. Overview List4.1.2 Merck & Co., Inc. Products & Services4.1.3 Merck & Co., Inc. Business Operation ConditionsTable Business Operation of Merck & Co., Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.2 GlaxoSmithKline plc (Company Profile, Sales Data etc.)4.2.1 GlaxoSmithKline plc ProfileTable GlaxoSmithKline plc Overview List4.2.2 GlaxoSmithKline plc Products & Services4.2.3 GlaxoSmithKline plc Business Operation ConditionsTable Business Operation of GlaxoSmithKline plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.3 Tesaro, Inc. (Company Profile, Sales Data etc.)4.3.1 Tesaro, Inc. ProfileTable Tesaro, Inc. Overview List4.3.2 Tesaro, Inc. Products & Services4.3.3 Tesaro, Inc. Business Operation ConditionsTable Business Operation of Tesaro, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.4 Helsinn Group (Company Profile, Sales Data etc.)4.4.1 Helsinn Group ProfileTable Helsinn Group Overview List4.4.2 Helsinn Group Products & Services4.4.3 Helsinn Group Business Operation ConditionsTable Business Operation of Helsinn Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.5 F. Hoffmann-La Roche Ltd. (Company Profile, Sales Data etc.)4.5.1 F. Hoffmann-La Roche Ltd. ProfileTable F. Hoffmann-La Roche Ltd. Overview List4.5.2 F. Hoffmann-La Roche Ltd. Products & Services4.5.3 F. Hoffmann-La Roche Ltd. Business Operation ConditionsTable Business Operation of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.6 Heron Therapeutics, Inc. (Company Profile, Sales Data etc.)4.6.1 Heron Therapeutics, Inc. ProfileTable Heron Therapeutics, Inc. Overview List4.6.2 Heron Therapeutics, Inc. Products & Services4.6.3 Heron Therapeutics, Inc. Business Operation ConditionsTable Business Operation of Heron Therapeutics, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.7 Dr. Reddy's Laboratories Ltd. (Company Profile, Sales Data etc.)4.7.1 Dr. Reddy's Laboratories Ltd. ProfileTable Dr. Reddy's Laboratories Ltd. Overview List4.7.2 Dr. Reddy's Laboratories Ltd. Products & Services4.7.3 Dr. Reddy's Laboratories Ltd. Business Operation ConditionsTable Business Operation of Dr. Reddy's Laboratories Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.8 Acacia Pharma (Company Profile, Sales Data etc.)4.8.1 Acacia Pharma ProfileTable Acacia Pharma Overview List4.8.2 Acacia Pharma Products & Services4.8.3 Acacia Pharma Business Operation ConditionsTable Business Operation of Acacia Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.9 Sun Pharmaceutical Industry Ltd. (Company Profile, Sales Data etc.)4.9.1 Sun Pharmaceutical Industry Ltd. ProfileTable Sun Pharmaceutical Industry Ltd. Overview List4.9.2 Sun Pharmaceutical Industry Ltd. Products & Services4.9.3 Sun Pharmaceutical Industry Ltd. Business Operation ConditionsTable Business Operation of Sun Pharmaceutical Industry Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.10 Otsuka Holdings Co., Ltd. (Company Profile, Sales Data etc.)4.10.1 Otsuka Holdings Co., Ltd. ProfileTable Otsuka Holdings Co., Ltd. Overview List4.10.2 Otsuka Holdings Co., Ltd. Products & Services4.10.3 Otsuka Holdings Co., Ltd. Business Operation ConditionsTable Business Operation of Otsuka Holdings Co., Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)5 Market Competition5.1 Company CompetitionTable Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Revenue 2016-2020, by Company, in USD MillionTable Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Revenue Share 2016-2020, by Company, in USD MillionFigure Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Revenue Share in 2020, by Company, in USD MillionTable Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume 2016-2020, by Company, in VolumeTable Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Share 2016-2020, by Company, in VolumeFigure Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Share in 2020, by Company, in Volume5.2 Regional Market by CompanyFigure North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Concentration, in 2020Figure Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Market Concentration, in 2020Figure Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs MMarket Concentration, in 2020Figure South America Chemotherapy-Induced Nausea and Vomiting Drugs Market Concentration, in 2020Figure Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Concentration, in 20206 Demand by End Market6.1 Demand Situation6.1.1 Demand in Serotonin Receptor AntagonistsFigure Chemotherapy-Induced Nausea and Vomiting Drugs Demand in Serotonin Receptor Antagonists, 2016-2020, in USD MillionFigure Chemotherapy-Induced Nausea and Vomiting Drugs Demand in Serotonin Receptor Antagonists, 2016-2020, in Volume6.1.2 Demand in NK1 Receptor AntagonistsFigure Chemotherapy-Induced Nausea and Vomiting Drugs Demand in NK1 Receptor Antagonists, 2016-2020, in USD MillionFigure Chemotherapy-Induced Nausea and Vomiting Drugs Demand in NK1 Receptor Antagonists, 2016-2020, in Volume6.2 Regional Demand ComparisonTable Regional Demand Comparison ListTable Major Application in Different Regions6.3 Demand ForecastTable Chemotherapy-Induced Nausea and Vomiting Drugs Demand Forecast 2021-2027, by Application, in USD MillionFigure Chemotherapy-Induced Nausea and Vomiting Drugs Market Growth 2021-2027, by Application, in USD MillionFigure Chemotherapy-Induced Nausea and Vomiting Drugs Market Share in 2027, by Application, in USD MillionTable Chemotherapy-Induced Nausea and Vomiting Drugs Demand Forecast 2021-2027, by Application, in VolumeTable Chemotherapy-Induced Nausea and Vomiting Drugs Market Growth 2021-2027, by Application, in VolumeTable Chemotherapy-Induced Nausea and Vomiting Drugs Market Share in 2027, by Application, in Volume6.4 Impact of the COVID-19 on the Demand7 Region Operation7.1 Regional ProductionTable Chemotherapy-Induced Nausea and Vomiting Drugs Production 2016-2020, by Region, in USD MillionTable Chemotherapy-Induced Nausea and Vomiting Drugs Production 2016-2020, by Region, in Volume7.2 Regional MarketTable Global Chemotherapy-Induced Nausea and Vomiting Drugs Market 2016-2020, by Region, in USD MillionTable Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Share 2016-2020, by Region, in USD MillionTable Global Chemotherapy-Induced Nausea and Vomiting Drugs Market 2016-2020, by Region, in VolumeTable Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Share 2016-2020, by Region, in Volume7.3 by Region7.3.1 North America7.3.1.1 OverviewFigure North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2016-2020, in USD MillionFigure North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2016-2020, in Volume7.3.1.2 by Country (U.S., Canada, Mexico)Table North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2016-2020, by Country, in USD MillionTable North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2016-2020, by Country, in Volume7.3.2 Europe7.3.2.1 OverviewFigure Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2016-2020, in USD MillionFigure Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2016-2020, in Volume7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)Table Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2016-2020, by Country, in USD MillionTable Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2016-2020, by Country, in Volume7.3.3 Asia-Pacific7.3.3.1 OverviewFigure Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2016-2020, in USD MillionFigure Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2016-2020, in Volume7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)Table Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2016-2020, by Country, in USD MillionTable Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2016-2020, by Country, in Volume7.3.4 South America7.3.4.1 OverviewFigure South America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2016-2020, in USD MillionFigure South America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2016-2020, in Volume7.3.4.2 by Country (Brazil, Argentina etc.)Table South America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2016-2020, by Country, in USD MillionTable South America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2016-2020, by Country, in Volume7.3.5 Middle East & Africa7.3.5.1 OverviewFigure Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2016-2020, in USD MillionFigure Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2016-2020, in Volume7.3.5.2 by Country (Saudi Arabia, South Africa etc.)Table Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2016-2020, by Country, in USD MillionTable Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2016-2020, by Country, in Volume7.4 Regional Import & Export7.5 Regional ForecastTable Chemotherapy-Induced Nausea and Vomiting Drugs Market Forecast 2021-2027, by Region, in USD MillionTable Chemotherapy-Induced Nausea and Vomiting Drugs Market Forecast 2021-2027, by Region, in Volume8 Marketing & Price8.1 Price and Margin8.1.1 Price Trends8.1.2 Factors of Price ChangeTable Price Factors List8.1.3 Manufacturers Gross Margin Analysis8.2 Marketing ChannelFigure Marketing Channels Overview9 Research Conclusion

List of Figure1. Figure Chemotherapy-Induced Nausea and Vomiting Drugs Industry Chain Structure2. Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Growth 2016-2020, by Type, in USD Million3. Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Growth 2016-2020, by Type, in Volume4. Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Revenue Share in 2020, by Company, in USD Million5. Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Share in 2020, by Company, in Volume6. Figure North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Concentration, in 20207. Figure Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Market Concentration, in 20208. Figure Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs MMarket Concentration, in 20209. Figure South America Chemotherapy-Induced Nausea and Vomiting Drugs Market Concentration, in 202010. Figure Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Concentration, in 202011. Figure Chemotherapy-Induced Nausea and Vomiting Drugs Demand in Serotonin Receptor Antagonists, 2016-2020, in USD Million12. Figure Chemotherapy-Induced Nausea and Vomiting Drugs Demand in Serotonin Receptor Antagonists, 2016-2020, in Volume13. Figure Chemotherapy-Induced Nausea and Vomiting Drugs Demand in NK1 Receptor Antagonists, 2016-2020, in USD Million14. Figure Chemotherapy-Induced Nausea and Vomiting Drugs Demand in NK1 Receptor Antagonists, 2016-2020, in Volume15. Figure Chemotherapy-Induced Nausea and Vomiting Drugs Market Growth 2021-2027, by Application, in USD Million16. Figure Chemotherapy-Induced Nausea and Vomiting Drugs Market Share in 2027, by Application, in USD Million17. Figure North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2016-2020, in USD Million18. Figure North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2016-2020, in Volume19. Figure Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2016-2020, in USD Million20. Figure Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2016-2020, in Volume21. Figure Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2016-2020, in USD Million22. Figure Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2016-2020, in Volume23. Figure South America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2016-2020, in USD Million24. Figure South America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2016-2020, in Volume25. Figure Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2016-2020, in USD Million26. Figure Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2016-2020, in Volume27. Figure Marketing Channels Overview


List of Table
List of Table1. Table Upstream Segment of Chemotherapy-Induced Nausea and Vomiting Drugs2. Table Application Segment of Chemotherapy-Induced Nausea and Vomiting Drugs3. Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market 2016-2027, by Application, in USD Million4. Table Major Company List of Akynzeo (Netupitant-Palonosetron FDC)5. Table Major Company List of Aloxi (Palonosetron)6. Table Major Company List of Emend (Aprepitant)7. Table Major Company List of Kytril Generic (Granisetron)8. Table Major Company List of Zofran Generic (Ondansetron)9. Table Major Company List of Pipeline Drugs10. Table Major Company List of SUSTOL (Granisetron Injection extended release)11. Table Major Company List of Rolapitant12. Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market 2016-2020, by Type, in USD Million13. Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market 2016-2020, by Type, in Volume14. Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Forecast 2021-2027, by Type, in USD Million15. Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Forecast 2021-2027, by Type, in Volume16. Table Merck & Co., Inc. Overview List17. Table Business Operation of Merck & Co., Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)18. Table GlaxoSmithKline plc Overview List19. Table Business Operation of GlaxoSmithKline plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)20. Table Tesaro, Inc. Overview List21. Table Business Operation of Tesaro, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)22. Table Helsinn Group Overview List23. Table Business Operation of Helsinn Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)24. Table F. Hoffmann-La Roche Ltd. Overview List25. Table Business Operation of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)26. Table Heron Therapeutics, Inc. Overview List27. Table Business Operation of Heron Therapeutics, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)28. Table Dr. Reddy's Laboratories Ltd. Overview List29. Table Business Operation of Dr. Reddy's Laboratories Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)30. Table Acacia Pharma Overview List31. Table Business Operation of Acacia Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)32. Table Sun Pharmaceutical Industry Ltd. Overview List33. Table Business Operation of Sun Pharmaceutical Industry Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)34. Table Otsuka Holdings Co., Ltd. Overview List35. Table Business Operation of Otsuka Holdings Co., Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)36. Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Revenue 2016-2020, by Company, in USD Million37. Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Revenue Share 2016-2020, by Company, in USD Million38. Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume 2016-2020, by Company, in Volume39. Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Share 2016-2020, by Company, in Volume40. Table Regional Demand Comparison List41. Table Major Application in Different Regions42. Table Chemotherapy-Induced Nausea and Vomiting Drugs Demand Forecast 2021-2027, by Application, in USD Million43. Table Chemotherapy-Induced Nausea and Vomiting Drugs Demand Forecast 2021-2027, by Application, in Volume44. Table Chemotherapy-Induced Nausea and Vomiting Drugs Market Growth 2021-2027, by Application, in Volume45. Table Chemotherapy-Induced Nausea and Vomiting Drugs Market Share in 2027, by Application, in Volume46. Table Chemotherapy-Induced Nausea and Vomiting Drugs Production 2016-2020, by Region, in USD Million47. Table Chemotherapy-Induced Nausea and Vomiting Drugs Production 2016-2020, by Region, in Volume48. Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market 2016-2020, by Region, in USD Million49. Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Share 2016-2020, by Region, in USD Million50. Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market 2016-2020, by Region, in Volume51. Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Share 2016-2020, by Region, in Volume52. Table North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2016-2020, by Country, in USD Million53. Table North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2016-2020, by Country, in Volume54. Table Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2016-2020, by Country, in USD Million55. Table Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2016-2020, by Country, in Volume56. Table Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2016-2020, by Country, in USD Million57. Table Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2016-2020, by Country, in Volume58. Table South America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2016-2020, by Country, in USD Million59. Table South America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2016-2020, by Country, in Volume60. Table Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2016-2020, by Country, in USD Million61. Table Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2016-2020, by Country, in Volume62. Table Chemotherapy-Induced Nausea and Vomiting Drugs Market Forecast 2021-2027, by Region, in USD Million63. Table Chemotherapy-Induced Nausea and Vomiting Drugs Market Forecast 2021-2027, by Region, in Volume64. Table Price Factors List

Chemotherapy-Induced Nausea and Vomiting Drugs Market Segments


Chemotherapy-Induced Nausea and Vomiting Drugs Product Type Outlook (Revenue, USD Million, 2021 2027)


  • Existing Drugs
  • Akynzeo (Netupitant-Palonosetron FDC)
  • Aloxi (Palonosetron)
  • Emend (Aprepitant)
  • Kytril Generic (Granisetron)
  • Zofran Generic (Ondansetron)
  • Pipeline Drugs
  • SUSTOL (Granisetron Injection extended release)
  • Rolapitant

Chemotherapy-Induced Nausea and Vomiting Drugs Application Outlook (Revenue, USD Million, 2021 2027)


  • Serotonin Receptor Antagonists
  • NK1 Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting Drugs Regional Outlook (Revenue, USD Million, 2021 2027)


  • North America
    • Chemotherapy-Induced Nausea and Vomiting Drugs market, By Product Type Outlook
      • Existing Drugs
      • Akynzeo (Netupitant-Palonosetron FDC)
      • Aloxi (Palonosetron)
      • Emend (Aprepitant)
      • Kytril Generic (Granisetron)
      • Zofran Generic (Ondansetron)
      • Pipeline Drugs
      • SUSTOL (Granisetron Injection extended release)
      • Rolapitant

    • Chemotherapy-Induced Nausea and Vomiting Drugs market, By Application Outlook
      • Serotonin Receptor Antagonists
      • NK1 Receptor Antagonists

  • Europe
    • Chemotherapy-Induced Nausea and Vomiting Drugs market, By Product Type Outlook
      • Existing Drugs
      • Akynzeo (Netupitant-Palonosetron FDC)
      • Aloxi (Palonosetron)
      • Emend (Aprepitant)
      • Kytril Generic (Granisetron)
      • Zofran Generic (Ondansetron)
      • Pipeline Drugs
      • SUSTOL (Granisetron Injection extended release)
      • Rolapitant

    • Chemotherapy-Induced Nausea and Vomiting Drugs market, By Application Outlook
      • Serotonin Receptor Antagonists
      • NK1 Receptor Antagonists

  • Asia Pacific
    • Chemotherapy-Induced Nausea and Vomiting Drugs market, By Product Type Outlook
      • Existing Drugs
      • Akynzeo (Netupitant-Palonosetron FDC)
      • Aloxi (Palonosetron)
      • Emend (Aprepitant)
      • Kytril Generic (Granisetron)
      • Zofran Generic (Ondansetron)
      • Pipeline Drugs
      • SUSTOL (Granisetron Injection extended release)
      • Rolapitant

    • Chemotherapy-Induced Nausea and Vomiting Drugs market, By Application Outlook
      • Serotonin Receptor Antagonists
      • NK1 Receptor Antagonists

  • Latin America
    • Chemotherapy-Induced Nausea and Vomiting Drugs market, By Product Type Outlook
      • Existing Drugs
      • Akynzeo (Netupitant-Palonosetron FDC)
      • Aloxi (Palonosetron)
      • Emend (Aprepitant)
      • Kytril Generic (Granisetron)
      • Zofran Generic (Ondansetron)
      • Pipeline Drugs
      • SUSTOL (Granisetron Injection extended release)
      • Rolapitant

    • Chemotherapy-Induced Nausea and Vomiting Drugs market, By Application Outlook
      • Serotonin Receptor Antagonists
      • NK1 Receptor Antagonists

  • Middle East & Africa
    • Chemotherapy-Induced Nausea and Vomiting Drugs market, By Product Type Outlook
      • Existing Drugs
      • Akynzeo (Netupitant-Palonosetron FDC)
      • Aloxi (Palonosetron)
      • Emend (Aprepitant)
      • Kytril Generic (Granisetron)
      • Zofran Generic (Ondansetron)
      • Pipeline Drugs
      • SUSTOL (Granisetron Injection extended release)
      • Rolapitant

    • Chemotherapy-Induced Nausea and Vomiting Drugs market, By Application Outlook
      • Serotonin Receptor Antagonists
      • NK1 Receptor Antagonists

Report Content:


Qualitative Analysis


  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porters analysis
  • PESTEL Analysis
  • Value Chain Analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Overview
    • Financials
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis


  • Market size, estimates, and forecasts from 2021 - 2027
  • Market revenue estimates for product type up to 2027
  • Market revenue estimates for application type up to 2027
  • Regional market size and forecast up to 2027
  • Company financials

Report Description


The Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Report provides Insightful information to the clients enhancing their basic leadership capacity identified with the global Chemotherapy-Induced Nausea and Vomiting Drugs Market business, including market dynamics, segmentation, competition, and regional growth. The strategy of expansion has been adopted by key players who are increasing their production capacities to cater to the increasing demand for various application.

New traders at intervals the Chemotherapy-Induced Nausea and Vomiting Drugs Market face strong competition from ancient world traders as they try with technological revolutions, dependableness and commonplace of Chemotherapy-Induced Nausea and Vomiting Drugs Market product affairs. The report is at risk of project regarding this Chemotherapy-Induced Nausea and Vomiting Drugs Market evolutions and additionally the magnitude of competition, value and extra.

Leading market players: (Option 1: Free 25% Customization Profiles of 5 Additional Companies of your Choice)


This business intelligence report offers profiling of reputed companies that are operating in the market. Companies such as:

  • Merck & Co., Inc.
  • GlaxoSmithKline plc
  • Tesaro, Inc.
  • Helsinn Group
  • F. Hoffmann-La Roche Ltd.
  • Heron Therapeutics, Inc.
  • Dr. Reddy's Laboratories Ltd.
  • Acacia Pharma
  • Sun Pharmaceutical Industry Ltd.
  • Otsuka Holdings Co., Ltd.

Others players have been profiled into detail so as to offer a glimpse of the market leaders. Moreover, parameters such as Chemotherapy-Induced Nausea and Vomiting Drugs related investment & spending and developments by major players of the market are tracked in this Global report.

Years considered for the study:


Chemotherapy-Induced Nausea and Vomiting Drugs Market

Chemotherapy-Induced Nausea and Vomiting Drugs Market

Report Highlights:


The Chemotherapy-Induced Nausea and Vomiting Drugs Market is widely partitioned reliant on the predictable updates in the enhancement of parameters for example, quality, trustworthiness, end customer solicitations, applications, and others. The Chemotherapy-Induced Nausea and Vomiting Drugs Market report contains general successful parameters, confinements, and besides has in detail illumination of the noteworthy data close by the present and future examples that may concern the advancement. The comprehensive Chemotherapy-Induced Nausea and Vomiting Drugs Market report elucidates within and outside representation of current advancements, parameters, and establishments.

The key regions analyzed in this study include North America, Europe, Japan, China, India, Korea, South East Asia, South America, Middle East and African countries. The leading players of Chemotherapy-Induced Nausea and Vomiting Drugs Market and their geographical presence across the globe are estimated based on production capacity, utilization ratio, consumer base, demand and supply scenario, profit margin and Chemotherapy-Induced Nausea and Vomiting Drugs marketers.

Data Lab Forecast performed primary as well as exhaustive secondary research for this study. We conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, DLF was able to include manufacturers that could not be identified due to the limitations of secondary research. We analysed product offerings, distribution channel and regional presence of all major companies in the industry.

Data Lab Forecast calculated the market size for the Chemotherapy-Induced Nausea and Vomiting Drugs market using a bottom-up approach, wherein manufacturers value data for different type (Existing Drugs, Akynzeo (Netupitant-Palonosetron FDC), Aloxi (Palonosetron), Emend (Aprepitant), Kytril Generic (Granisetron), Zofran Generic (Ondansetron), Pipeline Drugs, SUSTOL (Granisetron Injection extended release), Rolapitant), of Chemotherapy-Induced Nausea and Vomiting Drugs market was recorded as well as forecast for the future years was made. Data Lab Forecast sourced these values from industry experts and company representatives, and externally validated through analyzing historical sales data of respective manufacturers to arrive at the overall market size. Various secondary sources such as company annual reports, white papers, investor presentations and financial reports were also studied by Data Lab Forecast.

Chemotherapy-Induced Nausea and Vomiting Drugs Market

Chemotherapy-Induced Nausea and Vomiting Drugs Market

Key Target Audience:


  • Chemotherapy-Induced Nausea and Vomiting Drugs market companies.
  • Research organizations and consulting companies.
  • Organizations, associations and alliances related to the Chemotherapy-Induced Nausea and Vomiting Drugs market industry.
  • Government bodies such as regulating authorities and policymakers.
  • Industry associations.

The study is useful in providing answers to several critical questions that are important for industry stakeholders, such as manufacturers, distributors, dealers and policymakers, about which market segments should be targeted over retail cosmetics outlets in coming years to strategize investments and capitalize on growth of the market.

Report Scope:


In this report, Chemotherapy-Induced Nausea and Vomiting Drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

In terms of type, the Global Chemotherapy-Induced Nausea and Vomiting Drugs market is segregated into:


The report includes in-detail references of all the notable product categories as well as application specifications. The product segment is described on the basis of key player development traits, sales overview, volume based returns and the like.

  • Existing Drugs
  • Akynzeo (Netupitant-Palonosetron FDC)
  • Aloxi (Palonosetron)
  • Emend (Aprepitant)
  • Kytril Generic (Granisetron)
  • Zofran Generic (Ondansetron)
  • Pipeline Drugs
  • SUSTOL (Granisetron Injection extended release)
  • Rolapitant

By end-user also classify into, the Global Chemotherapy-Induced Nausea and Vomiting Drugs market:


Global Chemotherapy-Induced Nausea and Vomiting Drugs market also specifically underpins end-use application scope and their improvements based on technological developments and consumer preferences.

  • Serotonin Receptor Antagonists
  • NK1 Receptor Antagonists

Highlights of this 2021-2027 Chemotherapy-Induced Nausea and Vomiting Drugs Market Report:

  • Market dynamics, Chemotherapy-Induced Nausea and Vomiting Drugs economy manufacturing, opportunities on the total pricing of this top manufacturer and improvement trend analysis;
  • Chemotherapy-Induced Nausea and Vomiting Drugs industry players at the general regional industry and economy synopsis;
  • Deep analysis of the most significant market players included by Worldwide Chemotherapy-Induced Nausea and Vomiting Drugs Market study report;
  • Understand more about the market plans that are increasingly now being adopted by leading Chemotherapy-Induced Nausea and Vomiting Drugs businesses;
  • Evaluation of this market character, namely market development drivers, essential challengers, inhibitors, and chances;
  • Strategically profile the key players and comprehensively analyze their growth strategies.

Competitive Landscape:

Company Profiles: Detailed analysis of the major companies presents in the Chemotherapy-Induced Nausea and Vomiting Drugs market.

Product Benchmarking: Benchmarking of most selling variant of all leading companies based on product type. In-depth analysis of benchmarking and recommendation on ideal product specifications.

Voice of Customer: Customer analysis by considering the major factors influencing the purchasing decision.

Available Customizations:

With the given market data, Data Lab Forecast offers customizations according to the companys specific needs. The following customization options are available for the report:

Channel Partner Analysis: Detailed list of distributors and dealers across the country.

Company Information: Detailed analysis and profiling of additional market players (up to five).

Product Information: Detailed analysis of new products in the market and their driving forces in the market.

In case you dont find what you are looking for, please get in touch with our custom research team at sales@datalabforecast.com
Table of Contents1 Industry Overview1.1 Chemotherapy-Induced Nausea and Vomiting Drugs IndustryFigure Chemotherapy-Induced Nausea and Vomiting Drugs Industry Chain Structure1.1.1 Overview1.1.2 Development of Chemotherapy-Induced Nausea and Vomiting Drugs1.2 Market Segment1.2.1 UpstreamTable Upstream Segment of Chemotherapy-Induced Nausea and Vomiting Drugs1.2.2 DownstreamTable Application Segment of Chemotherapy-Induced Nausea and Vomiting DrugsTable Global Chemotherapy-Induced Nausea and Vomiting Drugs Market 2016-2027, by Application, in USD Million1.2.3 COVID-19 Impact1.3 Cost Analysis2 Industry Environment (PEST Analysis)2.1 Policy2.2 Economics2.3 Sociology2.4 Technology3 Chemotherapy-Induced Nausea and Vomiting Drugs Market by Type3.1 By Type3.1.1 Existing DrugsTable Major Company List of Existing Drugs3.1.2 Akynzeo (Netupitant-Palonosetron FDC)Table Major Company List of Akynzeo (Netupitant-Palonosetron FDC)3.1.3 Aloxi (Palonosetron)Table Major Company List of Aloxi (Palonosetron)3.1.4 Emend (Aprepitant)Table Major Company List of Emend (Aprepitant)3.1.5 Kytril Generic (Granisetron)Table Major Company List of Kytril Generic (Granisetron)3.1.6 Zofran Generic (Ondansetron)Table Major Company List of Zofran Generic (Ondansetron)3.1.7 Pipeline DrugsTable Major Company List of Pipeline Drugs3.1.8 SUSTOL (Granisetron Injection extended release)Table Major Company List of SUSTOL (Granisetron Injection extended release)3.1.9 RolapitantTable Major Company List of Rolapitant3.2 Market SizeTable Global Chemotherapy-Induced Nausea and Vomiting Drugs Market 2016-2020, by Type, in USD MillionFigure Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Growth 2016-2020, by Type, in USD MillionTable Global Chemotherapy-Induced Nausea and Vomiting Drugs Market 2016-2020, by Type, in VolumeFigure Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Growth 2016-2020, by Type, in Volume3.3 Market ForecastTable Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Forecast 2021-2027, by Type, in USD MillionTable Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Forecast 2021-2027, by Type, in Volume4 Major Companies List4.1 Merck & Co., Inc. (Company Profile, Sales Data etc.)4.1.1 Merck & Co., Inc. ProfileTable Merck & Co., Inc. Overview List4.1.2 Merck & Co., Inc. Products & Services4.1.3 Merck & Co., Inc. Business Operation ConditionsTable Business Operation of Merck & Co., Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.2 GlaxoSmithKline plc (Company Profile, Sales Data etc.)4.2.1 GlaxoSmithKline plc ProfileTable GlaxoSmithKline plc Overview List4.2.2 GlaxoSmithKline plc Products & Services4.2.3 GlaxoSmithKline plc Business Operation ConditionsTable Business Operation of GlaxoSmithKline plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.3 Tesaro, Inc. (Company Profile, Sales Data etc.)4.3.1 Tesaro, Inc. ProfileTable Tesaro, Inc. Overview List4.3.2 Tesaro, Inc. Products & Services4.3.3 Tesaro, Inc. Business Operation ConditionsTable Business Operation of Tesaro, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.4 Helsinn Group (Company Profile, Sales Data etc.)4.4.1 Helsinn Group ProfileTable Helsinn Group Overview List4.4.2 Helsinn Group Products & Services4.4.3 Helsinn Group Business Operation ConditionsTable Business Operation of Helsinn Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.5 F. Hoffmann-La Roche Ltd. (Company Profile, Sales Data etc.)4.5.1 F. Hoffmann-La Roche Ltd. ProfileTable F. Hoffmann-La Roche Ltd. Overview List4.5.2 F. Hoffmann-La Roche Ltd. Products & Services4.5.3 F. Hoffmann-La Roche Ltd. Business Operation ConditionsTable Business Operation of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.6 Heron Therapeutics, Inc. (Company Profile, Sales Data etc.)4.6.1 Heron Therapeutics, Inc. ProfileTable Heron Therapeutics, Inc. Overview List4.6.2 Heron Therapeutics, Inc. Products & Services4.6.3 Heron Therapeutics, Inc. Business Operation ConditionsTable Business Operation of Heron Therapeutics, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.7 Dr. Reddy's Laboratories Ltd. (Company Profile, Sales Data etc.)4.7.1 Dr. Reddy's Laboratories Ltd. ProfileTable Dr. Reddy's Laboratories Ltd. Overview List4.7.2 Dr. Reddy's Laboratories Ltd. Products & Services4.7.3 Dr. Reddy's Laboratories Ltd. Business Operation ConditionsTable Business Operation of Dr. Reddy's Laboratories Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.8 Acacia Pharma (Company Profile, Sales Data etc.)4.8.1 Acacia Pharma ProfileTable Acacia Pharma Overview List4.8.2 Acacia Pharma Products & Services4.8.3 Acacia Pharma Business Operation ConditionsTable Business Operation of Acacia Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.9 Sun Pharmaceutical Industry Ltd. (Company Profile, Sales Data etc.)4.9.1 Sun Pharmaceutical Industry Ltd. ProfileTable Sun Pharmaceutical Industry Ltd. Overview List4.9.2 Sun Pharmaceutical Industry Ltd. Products & Services4.9.3 Sun Pharmaceutical Industry Ltd. Business Operation ConditionsTable Business Operation of Sun Pharmaceutical Industry Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.10 Otsuka Holdings Co., Ltd. (Company Profile, Sales Data etc.)4.10.1 Otsuka Holdings Co., Ltd. ProfileTable Otsuka Holdings Co., Ltd. Overview List4.10.2 Otsuka Holdings Co., Ltd. Products & Services4.10.3 Otsuka Holdings Co., Ltd. Business Operation ConditionsTable Business Operation of Otsuka Holdings Co., Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)5 Market Competition5.1 Company CompetitionTable Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Revenue 2016-2020, by Company, in USD MillionTable Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Revenue Share 2016-2020, by Company, in USD MillionFigure Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Revenue Share in 2020, by Company, in USD MillionTable Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume 2016-2020, by Company, in VolumeTable Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Share 2016-2020, by Company, in VolumeFigure Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Share in 2020, by Company, in Volume5.2 Regional Market by CompanyFigure North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Concentration, in 2020Figure Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Market Concentration, in 2020Figure Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs MMarket Concentration, in 2020Figure South America Chemotherapy-Induced Nausea and Vomiting Drugs Market Concentration, in 2020Figure Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Concentration, in 20206 Demand by End Market6.1 Demand Situation6.1.1 Demand in Serotonin Receptor AntagonistsFigure Chemotherapy-Induced Nausea and Vomiting Drugs Demand in Serotonin Receptor Antagonists, 2016-2020, in USD MillionFigure Chemotherapy-Induced Nausea and Vomiting Drugs Demand in Serotonin Receptor Antagonists, 2016-2020, in Volume6.1.2 Demand in NK1 Receptor AntagonistsFigure Chemotherapy-Induced Nausea and Vomiting Drugs Demand in NK1 Receptor Antagonists, 2016-2020, in USD MillionFigure Chemotherapy-Induced Nausea and Vomiting Drugs Demand in NK1 Receptor Antagonists, 2016-2020, in Volume6.2 Regional Demand ComparisonTable Regional Demand Comparison ListTable Major Application in Different Regions6.3 Demand ForecastTable Chemotherapy-Induced Nausea and Vomiting Drugs Demand Forecast 2021-2027, by Application, in USD MillionFigure Chemotherapy-Induced Nausea and Vomiting Drugs Market Growth 2021-2027, by Application, in USD MillionFigure Chemotherapy-Induced Nausea and Vomiting Drugs Market Share in 2027, by Application, in USD MillionTable Chemotherapy-Induced Nausea and Vomiting Drugs Demand Forecast 2021-2027, by Application, in VolumeTable Chemotherapy-Induced Nausea and Vomiting Drugs Market Growth 2021-2027, by Application, in VolumeTable Chemotherapy-Induced Nausea and Vomiting Drugs Market Share in 2027, by Application, in Volume6.4 Impact of the COVID-19 on the Demand7 Region Operation7.1 Regional ProductionTable Chemotherapy-Induced Nausea and Vomiting Drugs Production 2016-2020, by Region, in USD MillionTable Chemotherapy-Induced Nausea and Vomiting Drugs Production 2016-2020, by Region, in Volume7.2 Regional MarketTable Global Chemotherapy-Induced Nausea and Vomiting Drugs Market 2016-2020, by Region, in USD MillionTable Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Share 2016-2020, by Region, in USD MillionTable Global Chemotherapy-Induced Nausea and Vomiting Drugs Market 2016-2020, by Region, in VolumeTable Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Share 2016-2020, by Region, in Volume7.3 by Region7.3.1 North America7.3.1.1 OverviewFigure North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2016-2020, in USD MillionFigure North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2016-2020, in Volume7.3.1.2 by Country (U.S., Canada, Mexico)Table North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2016-2020, by Country, in USD MillionTable North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2016-2020, by Country, in Volume7.3.2 Europe7.3.2.1 OverviewFigure Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2016-2020, in USD MillionFigure Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2016-2020, in Volume7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)Table Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2016-2020, by Country, in USD MillionTable Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2016-2020, by Country, in Volume7.3.3 Asia-Pacific7.3.3.1 OverviewFigure Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2016-2020, in USD MillionFigure Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2016-2020, in Volume7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)Table Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2016-2020, by Country, in USD MillionTable Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2016-2020, by Country, in Volume7.3.4 South America7.3.4.1 OverviewFigure South America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2016-2020, in USD MillionFigure South America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2016-2020, in Volume7.3.4.2 by Country (Brazil, Argentina etc.)Table South America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2016-2020, by Country, in USD MillionTable South America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2016-2020, by Country, in Volume7.3.5 Middle East & Africa7.3.5.1 OverviewFigure Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2016-2020, in USD MillionFigure Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2016-2020, in Volume7.3.5.2 by Country (Saudi Arabia, South Africa etc.)Table Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2016-2020, by Country, in USD MillionTable Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2016-2020, by Country, in Volume7.4 Regional Import & Export7.5 Regional ForecastTable Chemotherapy-Induced Nausea and Vomiting Drugs Market Forecast 2021-2027, by Region, in USD MillionTable Chemotherapy-Induced Nausea and Vomiting Drugs Market Forecast 2021-2027, by Region, in Volume8 Marketing & Price8.1 Price and Margin8.1.1 Price Trends8.1.2 Factors of Price ChangeTable Price Factors List8.1.3 Manufacturers Gross Margin Analysis8.2 Marketing ChannelFigure Marketing Channels Overview9 Research Conclusion

Chemotherapy-Induced Nausea and Vomiting Drugs Market Segments


Chemotherapy-Induced Nausea and Vomiting Drugs Product Type Outlook (Revenue, USD Million, 2021 2027)


  • Existing Drugs
  • Akynzeo (Netupitant-Palonosetron FDC)
  • Aloxi (Palonosetron)
  • Emend (Aprepitant)
  • Kytril Generic (Granisetron)
  • Zofran Generic (Ondansetron)
  • Pipeline Drugs
  • SUSTOL (Granisetron Injection extended release)
  • Rolapitant

Chemotherapy-Induced Nausea and Vomiting Drugs Application Outlook (Revenue, USD Million, 2021 2027)


  • Serotonin Receptor Antagonists
  • NK1 Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting Drugs Regional Outlook (Revenue, USD Million, 2021 2027)


  • North America
    • Chemotherapy-Induced Nausea and Vomiting Drugs market, By Product Type Outlook
      • Existing Drugs
      • Akynzeo (Netupitant-Palonosetron FDC)
      • Aloxi (Palonosetron)
      • Emend (Aprepitant)
      • Kytril Generic (Granisetron)
      • Zofran Generic (Ondansetron)
      • Pipeline Drugs
      • SUSTOL (Granisetron Injection extended release)
      • Rolapitant

    • Chemotherapy-Induced Nausea and Vomiting Drugs market, By Application Outlook
      • Serotonin Receptor Antagonists
      • NK1 Receptor Antagonists

  • Europe
    • Chemotherapy-Induced Nausea and Vomiting Drugs market, By Product Type Outlook
      • Existing Drugs
      • Akynzeo (Netupitant-Palonosetron FDC)
      • Aloxi (Palonosetron)
      • Emend (Aprepitant)
      • Kytril Generic (Granisetron)
      • Zofran Generic (Ondansetron)
      • Pipeline Drugs
      • SUSTOL (Granisetron Injection extended release)
      • Rolapitant

    • Chemotherapy-Induced Nausea and Vomiting Drugs market, By Application Outlook
      • Serotonin Receptor Antagonists
      • NK1 Receptor Antagonists

  • Asia Pacific
    • Chemotherapy-Induced Nausea and Vomiting Drugs market, By Product Type Outlook
      • Existing Drugs
      • Akynzeo (Netupitant-Palonosetron FDC)
      • Aloxi (Palonosetron)
      • Emend (Aprepitant)
      • Kytril Generic (Granisetron)
      • Zofran Generic (Ondansetron)
      • Pipeline Drugs
      • SUSTOL (Granisetron Injection extended release)
      • Rolapitant

    • Chemotherapy-Induced Nausea and Vomiting Drugs market, By Application Outlook
      • Serotonin Receptor Antagonists
      • NK1 Receptor Antagonists

  • Latin America
    • Chemotherapy-Induced Nausea and Vomiting Drugs market, By Product Type Outlook
      • Existing Drugs
      • Akynzeo (Netupitant-Palonosetron FDC)
      • Aloxi (Palonosetron)
      • Emend (Aprepitant)
      • Kytril Generic (Granisetron)
      • Zofran Generic (Ondansetron)
      • Pipeline Drugs
      • SUSTOL (Granisetron Injection extended release)
      • Rolapitant

    • Chemotherapy-Induced Nausea and Vomiting Drugs market, By Application Outlook
      • Serotonin Receptor Antagonists
      • NK1 Receptor Antagonists

  • Middle East & Africa
    • Chemotherapy-Induced Nausea and Vomiting Drugs market, By Product Type Outlook
      • Existing Drugs
      • Akynzeo (Netupitant-Palonosetron FDC)
      • Aloxi (Palonosetron)
      • Emend (Aprepitant)
      • Kytril Generic (Granisetron)
      • Zofran Generic (Ondansetron)
      • Pipeline Drugs
      • SUSTOL (Granisetron Injection extended release)
      • Rolapitant

    • Chemotherapy-Induced Nausea and Vomiting Drugs market, By Application Outlook
      • Serotonin Receptor Antagonists
      • NK1 Receptor Antagonists

Report Content:


Qualitative Analysis


  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porters analysis
  • PESTEL Analysis
  • Value Chain Analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Overview
    • Financials
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis


  • Market size, estimates, and forecasts from 2021 - 2027
  • Market revenue estimates for product type up to 2027
  • Market revenue estimates for application type up to 2027
  • Regional market size and forecast up to 2027
  • Company financials
List of Figure1. Figure Chemotherapy-Induced Nausea and Vomiting Drugs Industry Chain Structure2. Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Growth 2016-2020, by Type, in USD Million3. Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Growth 2016-2020, by Type, in Volume4. Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Revenue Share in 2020, by Company, in USD Million5. Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Share in 2020, by Company, in Volume6. Figure North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Concentration, in 20207. Figure Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Market Concentration, in 20208. Figure Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs MMarket Concentration, in 20209. Figure South America Chemotherapy-Induced Nausea and Vomiting Drugs Market Concentration, in 202010. Figure Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Concentration, in 202011. Figure Chemotherapy-Induced Nausea and Vomiting Drugs Demand in Serotonin Receptor Antagonists, 2016-2020, in USD Million12. Figure Chemotherapy-Induced Nausea and Vomiting Drugs Demand in Serotonin Receptor Antagonists, 2016-2020, in Volume13. Figure Chemotherapy-Induced Nausea and Vomiting Drugs Demand in NK1 Receptor Antagonists, 2016-2020, in USD Million14. Figure Chemotherapy-Induced Nausea and Vomiting Drugs Demand in NK1 Receptor Antagonists, 2016-2020, in Volume15. Figure Chemotherapy-Induced Nausea and Vomiting Drugs Market Growth 2021-2027, by Application, in USD Million16. Figure Chemotherapy-Induced Nausea and Vomiting Drugs Market Share in 2027, by Application, in USD Million17. Figure North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2016-2020, in USD Million18. Figure North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2016-2020, in Volume19. Figure Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2016-2020, in USD Million20. Figure Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2016-2020, in Volume21. Figure Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2016-2020, in USD Million22. Figure Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2016-2020, in Volume23. Figure South America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2016-2020, in USD Million24. Figure South America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2016-2020, in Volume25. Figure Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2016-2020, in USD Million26. Figure Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2016-2020, in Volume27. Figure Marketing Channels Overview


List of Table
List of Table1. Table Upstream Segment of Chemotherapy-Induced Nausea and Vomiting Drugs2. Table Application Segment of Chemotherapy-Induced Nausea and Vomiting Drugs3. Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market 2016-2027, by Application, in USD Million4. Table Major Company List of Akynzeo (Netupitant-Palonosetron FDC)5. Table Major Company List of Aloxi (Palonosetron)6. Table Major Company List of Emend (Aprepitant)7. Table Major Company List of Kytril Generic (Granisetron)8. Table Major Company List of Zofran Generic (Ondansetron)9. Table Major Company List of Pipeline Drugs10. Table Major Company List of SUSTOL (Granisetron Injection extended release)11. Table Major Company List of Rolapitant12. Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market 2016-2020, by Type, in USD Million13. Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market 2016-2020, by Type, in Volume14. Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Forecast 2021-2027, by Type, in USD Million15. Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Forecast 2021-2027, by Type, in Volume16. Table Merck & Co., Inc. Overview List17. Table Business Operation of Merck & Co., Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)18. Table GlaxoSmithKline plc Overview List19. Table Business Operation of GlaxoSmithKline plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)20. Table Tesaro, Inc. Overview List21. Table Business Operation of Tesaro, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)22. Table Helsinn Group Overview List23. Table Business Operation of Helsinn Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)24. Table F. Hoffmann-La Roche Ltd. Overview List25. Table Business Operation of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)26. Table Heron Therapeutics, Inc. Overview List27. Table Business Operation of Heron Therapeutics, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)28. Table Dr. Reddy's Laboratories Ltd. Overview List29. Table Business Operation of Dr. Reddy's Laboratories Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)30. Table Acacia Pharma Overview List31. Table Business Operation of Acacia Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)32. Table Sun Pharmaceutical Industry Ltd. Overview List33. Table Business Operation of Sun Pharmaceutical Industry Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)34. Table Otsuka Holdings Co., Ltd. Overview List35. Table Business Operation of Otsuka Holdings Co., Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)36. Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Revenue 2016-2020, by Company, in USD Million37. Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Revenue Share 2016-2020, by Company, in USD Million38. Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume 2016-2020, by Company, in Volume39. Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Share 2016-2020, by Company, in Volume40. Table Regional Demand Comparison List41. Table Major Application in Different Regions42. Table Chemotherapy-Induced Nausea and Vomiting Drugs Demand Forecast 2021-2027, by Application, in USD Million43. Table Chemotherapy-Induced Nausea and Vomiting Drugs Demand Forecast 2021-2027, by Application, in Volume44. Table Chemotherapy-Induced Nausea and Vomiting Drugs Market Growth 2021-2027, by Application, in Volume45. Table Chemotherapy-Induced Nausea and Vomiting Drugs Market Share in 2027, by Application, in Volume46. Table Chemotherapy-Induced Nausea and Vomiting Drugs Production 2016-2020, by Region, in USD Million47. Table Chemotherapy-Induced Nausea and Vomiting Drugs Production 2016-2020, by Region, in Volume48. Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market 2016-2020, by Region, in USD Million49. Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Share 2016-2020, by Region, in USD Million50. Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market 2016-2020, by Region, in Volume51. Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Share 2016-2020, by Region, in Volume52. Table North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2016-2020, by Country, in USD Million53. Table North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2016-2020, by Country, in Volume54. Table Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2016-2020, by Country, in USD Million55. Table Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2016-2020, by Country, in Volume56. Table Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2016-2020, by Country, in USD Million57. Table Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2016-2020, by Country, in Volume58. Table South America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2016-2020, by Country, in USD Million59. Table South America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2016-2020, by Country, in Volume60. Table Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2016-2020, by Country, in USD Million61. Table Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2016-2020, by Country, in Volume62. Table Chemotherapy-Induced Nausea and Vomiting Drugs Market Forecast 2021-2027, by Region, in USD Million63. Table Chemotherapy-Induced Nausea and Vomiting Drugs Market Forecast 2021-2027, by Region, in Volume64. Table Price Factors List
Choose License Type
  • $4250  
  • $6250  
  • $8250  

Secure Payment


img1
Frequently Asked Questions ?
  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Immediate / Within 24-48 hours - Working days

  • Online Payments with PayPal and CCavenue

  • You can order a report by picking any of the payment methods which is bank wire or online payment through any Debit/Credit card or PayPal.

  • Email

  • Hard Copy

Related Reports

Antibody Drug Conjugates Contract Manufacturing Market

Report Description According to the new market study, we provide a comprehensive and in-depth analys

Read More

Therapeutic Drug Monitoring Market

Report Description According to the new market study, we provide a comprehensive and in-depth analys

Read More

Topical Drug Delivery System Market

Report Description According to the new market study, we provide a comprehensive and in-depth analys

Read More


Request Sample   
Buy Now